retatrutide study Phase III demonstrates 30% weight loss retatrutide study results Retatrutide: A

& Norgren, S

This gives certainty regarding its clinical application (104)

GLP-1 receptors are expressed in key reward-related brain regions , including: The ventral tegmental area (VTA) and nucleus accumbens , which form the core of the mesolimbic dopamine pathway The prefrontal cortex , involved in executive function and impulse control The amygdala , which processes emotional salience and stress responses The prevailing hypothesis suggests that GLP-1 receptor activation may modulate dopamine signalling in reward circuits

The difference is not about one being better than the other, but about their distinct roles in a skincare approach

Jefferies H, Coster J, Khalil A, Bot J, McCauley RD, Hall JC

Higher glutathione levels may support maternal and fetal protection